eligibility for overall study are listed below. there may be additional appendix-specific criteria. inclusion criteria: * completed informed consent * age ≥ 30 years old * confirmed sars-cov-2 infection by any authorized or approved polymerase chain reaction (pcr) or antigen test collected within 10 days of screening * two or more current symptoms of acute infection for ≤7 days. symptoms include the following: fatigue, dyspnea, fever, cough, nausea, vomiting, diarrhea, body aches, chills, headache, sore throat, nasal symptoms, new loss of sense of taste or smell

eligibility for overall study are listed below. there may be additional appendix-specific criteria. inclusion criteria: * completed informed consent * age ≥ 30 years old * confirmed sars-cov-2 infection by any authorized or approved polymerase chain reaction (pcr) or antigen test collected within 10 days of screening * two or more current symptoms of acute infection for ≤7 days. symptoms include the following: fatigue, dyspnea, fever, cough, nausea, vomiting, diarrhea, body aches, chills, headache, sore throat, nasal symptoms, new loss of sense of taste or smell

eligibility for overall study are listed below. there may be additional appendix-specific criteria. inclusion criteria: completed informed consent age ≥ 30 years old confirmed sars-cov-2 infection by any authorized or approved polymerase chain reaction (pcr) or antigen test collected within 10 days of screening two or more current symptoms of acute infection for ≤7 days. symptoms include the following: fatigue, dyspnea, fever, cough, nausea, vomiting, diarrhea, body aches, chills, headache, sore throat, nasal symptoms, new loss of sense of taste or smell

eligibility for overall study are listed below. there may be additional appendix-specific criteria. inclusion criteria: completed informed consent age ≥ 30 years old confirmed sars-cov-2 infection by any authorized or approved polymerase chain reaction (pcr) or antigen test collected within 10 days of screening two or more current symptoms of acute infection for ≤7 days. symptoms include the following: fatigue, dyspnea, fever, cough, nausea, vomiting, diarrhea, body aches, chills, headache, sore throat, nasal symptoms, new loss of sense of taste or smell

inclusion criteria: - completed informed consent - age ≥ 30 years old - confirmed sars-cov-2 infection by any authorized or approved polymerase chain reaction (pcr) or antigen test collected within 10 days of screening - two or more current symptoms of acute infection for ≤7 days. symptoms include the following: fatigue, dyspnea, fever, cough, nausea, vomiting, diarrhea, body aches, chills, headache, sore throat, nasal symptoms, new loss of sense of taste or smell

inclusion criteria: - completed informed consent - age ≥ 30 years old - confirmed sars-cov-2 infection by any authorized or approved polymerase chain reaction (pcr) or antigen test collected within 10 days of screening - two or more current symptoms of acute infection for ≤7 days. symptoms include the following: fatigue, dyspnea, fever, cough, nausea, vomiting, diarrhea, body aches, chills, headache, sore throat, nasal symptoms, new loss of sense of taste or smell